Clinical Trial of Vit D and Calcium for Recurrent BPPV

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOttawa Hospital Research Institute

About this trial

Randomized double blind placebo controlled trial of vitamin D supplements, with or without calcium supplementation, versus placebo in reduction of recurrences in BPPV.

Eligibility criteria

Qualifiers

Age 18 years or older

2 or more distinct episodes of benign paroxysmal positional vertigo within a 12-month period on history

At least 1 episode diagnosed based on physical examination by trained study personnel, meeting the diagnostic criteria of the Bárány Society

Episodes separated in time, with a minimum of 1 week symptom-free between episodes

Disqualifiers

have another identifiable cause of vertigo identified on history or physical examination

have a history of allergy or medically significant adverse reaction to vitamin D or calcium carbonate

have a chronic medical disorder which is a contraindication to vitamin D or calcium carbonate supplementation, including uncontrolled hyperparathyroidism, nephrolithiasis, or GI malabsorption disorders

are on loop diuretic agents or thiazides

Trial design

Treatments tested in this trial

  • vitamin D +/- calcium
  • Placebo

Treatment groups

860 Participants
are divided into 2 treatment groups

Locations

This trial has no locations